This report describes one woman who was 54 years old when she had breast cancer that later spread to her thyroid gland. The patient received radiotherapy, chemotherapy, and endocrine therapy for her breast cancer. She is still alive, though the study did not report how long she has lived or any specific survival rates. Because this is a single case, the results cannot be used to predict outcomes for other patients. The main point is that doctors should suspect breast cancer if a patient with a history of the disease develops new thyroid nodules. Diagnosis often involves fine-needle aspiration and immunohistochemistry tests. Surgery is the main treatment option when needed. This information comes from a case report published as a review, which means it shares details of one experience rather than testing a broad group of people. Readers should understand that one story does not prove what happens to everyone. Always talk with a doctor about personal risks and treatment choices.
Breast cancer can spread to the thyroid gland in rare cases
Photo by Sasun Bughdaryan / Unsplash
What this means for you:
Doctors should suspect breast cancer if a patient with a history of the disease develops new thyroid nodules. More on Breast Cancer
Meta-analysis links emotional distress to worse outcomes in advanced lung cancer Emotional distress linked to worse lung cancer survival
Frontiers · May 21, 2026
Breast cancer chemotherapy associated with taste alterations and dietary changes in Italian cohort Chemo Taste Changes: Patients Feel More Than Tests Detect
Frontiers · Apr 22, 2026
Sequential paclitaxel-palbociclib showed no difference in ORR versus reverse sequence in ER+/HER2- breast cancer New Test Predicts Who Needs Chemo in Breast Cancer
· Apr 12, 2026
Network meta-analysis suggests immune checkpoint inhibitor regimens improve survival in advanced gastric cancer compared to chemotherapy alone New analysis suggests dual-target immune checkpoint inhibitors may improve survival for advanced gastric cancer patients
· May 24, 2026